search
AstraZeneca
Trends
- 1Hansoh's Tagrisso rival loses EU approval after AstraZeneca challenge▼Hansoh’s Tagrisso rival loses EU approval after AstraZeneca legal challenge
A copycat version of AstraZeneca's blockbuster lung cancer drug Tagrisso, made by China's Hansoh Pharmaceutical, has lost its European Union approval following a legal challenge from AstraZeneca. The decision removes the rival medicine from the EU market, marking a win for AstraZeneca in its defence of one of its biggest sellers.